C5H6N2O4
158.11 g/mol
Pharmaceutical IntermediateWarning
D-Hydroorotic acid
CAS5988-53-4EC621-647-0
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
D-Hydroorotic acid is a pharmaceutical intermediate used primarily in peptide synthesis. It is a dihydroorotic acid enantiomer and serves as a building block in the production of specialized peptides.
Pharmaceutical intermediate for peptide synthesisBuilding block for the synthesis of (R)-dihydroorotic acid derivatives
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 5988-53-4
Related Compounds
ReferenceSame Category
4-Chloro-2,3-dimethylpyridine 1-oxide
CAS59886-90-7
pharmaceutical intermediate
ReferenceSame Category
(R)-pantolactone
CAS599-04-2
pharmaceutical intermediate
ReferenceSame Category
4-(1,2,4-Oxadiazol-3-yl)aniline
CAS59908-70-2
pharmaceutical intermediate
ReferenceSame Category
Tyramine hydrochloride
CAS60-19-5
pharmaceutical intermediate
Referencestereoisomer of
L-hydroorotic acid
CAS5988-19-2
pharmaceutical intermediate
Referencesame scaffold
Dihydro Uracil-d4
CAS334473-41-5
research compound
Safety Reference
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name
(4R)-2,6-dioxo-1,3-diazinane-4-carboxylic acid
InChIKey
UFIVEPVSAGBUSI-UWTATZPHSA-N
SMILES
C1[C@@H](NC(=O)NC1=O)C(=O)O
Synonyms (14)
- (R)-4,5-dihydroorotic acid
- (R)-dihydroorotic acid
- 4,5-dihydro-D-orotic acid
- D-4,5-dihydroorotic acid
- D-Hydroorotic acid
- Degarelix Impurity 9
- Hydroorotic acid D-form
- Hydroorotic acid, D-